» Articles » PMID: 36267435

Presentation and Management of Nervous System Cavernous Malformations in Children: A Systematic Review and Case Report

Overview
Journal Brain Circ
Date 2022 Oct 21
PMID 36267435
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral cavernous malformations (CMs) are slow-flow vascular lesions that affect up to 0.5% of the pediatric population. These lesions are at risk for hemorrhage, causing seizures, and leading to neurological deficits. Here, we conduct a literature review and then present a report of a supratentorial CM in a 2-year-old patient with no significant past medical history who presented at our institution with 1 month of eye twitching. We performed a literature search of five databases of all articles published before 2020. Our inclusion criteria included cohort and case series of children with mean age under 12 years. Our search yielded 497 unique articles, of which 16 met our inclusion criteria. In our pooled literature analysis, a total of 558 children were included, 8.3% of which had a positive family history and 15.9% had multiple CMs. About 46.1% of the children had seizures, and 88.4% of those who underwent surgery had a total resection. About 85.1% of those with epilepsy were Engel Class 1 postsurgery. Over a mean follow-up of 4.1 years, 3.4% of patients had additional neurological deficits, including paresis and speech deficits. Our analysis of published literature shows surgical intervention should be considered first-line therapy for patients who are symptomatic from CM, present with seizure, and have surgically accessible lesions. Additional work is needed on outcomes and long-term effects of minimally invasive treatments, including radiosurgery and laser ablation, in pediatric populations.

Citing Articles

Tumour mimics in paediatric neuroimaging.

Coppola F, Lobel U, Morana G, Reddy N, Mankad K Neuroradiology. 2024; 67(1):7-24.

PMID: 39576299 DOI: 10.1007/s00234-024-03507-8.


Cavernous Malformations of the Central Nervous System: A Comprehensive Review of Pathophysiology, Diagnosis, and Management.

Das K, Sen J, Borode A Cureus. 2024; 16(8):e67591.

PMID: 39310452 PMC: 11416750. DOI: 10.7759/cureus.67591.


Surgical treatment of cavernous malformation-related epilepsy in children: case series, systematic review, and meta-analysis.

Bosisio L, Cognolato E, Nobile G, Mancardi M, Nobili L, Pacetti M Neurosurg Rev. 2024; 47(1):251.

PMID: 38819574 DOI: 10.1007/s10143-024-02491-0.

References
1.
Mosca L, Pileggi S, Avemaria F, Tarlarini C, Sole Cigoli M, Capra V . De novo MGC4607 gene heterozygous missense variants in a child with multiple cerebral cavernous malformations. J Mol Neurosci. 2012; 47(3):475-80. DOI: 10.1007/s12031-012-9741-5. View

2.
Porter P, Willinsky R, Harper W, Wallace M . Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997; 87(2):190-7. DOI: 10.3171/jns.1997.87.2.0190. View

3.
Spiegler S, Najm J, Liu J, Gkalympoudis S, Schroder W, Borck G . High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors. Mol Genet Genomic Med. 2014; 2(2):176-85. PMC: 3960060. DOI: 10.1002/mgg3.60. View

4.
Li D, Hao S, Tang J, Xiao X, Jia G, Wu Z . Clinical course of untreated pediatric brainstem cavernous malformations: hemorrhage risk and functional recovery. J Neurosurg Pediatr. 2014; 13(5):471-83. DOI: 10.3171/2014.2.PEDS13487. View

5.
Zhou Z, Tang A, Wong W, Bamezai S, Goddard L, Shenkar R . Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016; 532(7597):122-6. PMC: 4864035. DOI: 10.1038/nature17178. View